Answers are grounded in this paper and cite their sources.
Maternal cell contamination (MCC) in prenatal samples poses a risk for misdiagnosis, and therefore, testing for contamination is necessary during genetic analysis of prenatal specimens. MCC testing is currently performed as a method separate from the diagnostic method. With the increasing application of whole exome sequencing (WES) in prenatal diagnosis, we sought to develop a method to estimate the level of contamination from WES data, aiming to eliminate the need for a separate MCC test.
No takes yet. Share an insight, caveat, or question.
Smeekens et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: